humanin has been researched along with Obesity* in 2 studies
2 other study(ies) available for humanin and Obesity
Article | Year |
---|---|
Metabolomic profile of diet-induced obesity mice in response to humanin and small humanin-like peptide 2 treatment.
The mitochondrial-derived peptides (MDPs) are a novel group of natural occurring peptides that have important signaling functions and biological activity. Both humanin and small-humanin-like peptide 2 (SHLP2) have been reported to act as insulin sensitizers and modulate metabolism.. By using a metabolomic approach, this study explores how the plasma metabolite profile is regulated in response to humanin and SHLP2 treatment in a diet-induced obesity (DIO) mouse model. The results also shed light on the potential mechanism underlying MDPs' insulin sensitization effects.. Plasma samples were obtained from DIO mice subjected to vehicle (water) treatment, or peptide treatment with either humanin analog S14G (HNG) or SHLP2 (n = 6 per group). Vehicle or peptides were given as intraperitoneal (IP) injections twice a day at dose of 2.5 mg/kg/injection for 3 days. Metabolites in plasma samples were comprehensively identified and quantified using UPLC-MS/MS.. HNG and SHLP2 administration significantly altered the concentrations of amino acid and lipid metabolites in plasma. Among all the metabolic pathways, the glutathione and sphingolipid metabolism responded most strongly to the peptide treatment.. The present study indicates that humanin and SHLP2 can lower several markers associated with age-related metabolic disorders. With the previous understanding of the effects of humanin and SHLP2 on cardiovascular function, insulin sensitization, and anti-inflammation, this metabolomic discovery provides a more comprehensive molecular explanation of the mechanism of action for humanin and SHLP2 treatment. Topics: Amino Acids; Animals; Anti-Obesity Agents; Diet; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Lipids; Male; Metabolome; Metabolomics; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Peptides | 2019 |
Central effects of humanin on hepatic triglyceride secretion.
Humanin (HN) is an endogenous mitochondria-associated peptide that has been shown to protect against various Alzheimer's disease-associated insults, myocardial ischemia-reperfusion injury, and reactive oxygen species-induced cell death. We have shown previously that HN improves whole body glucose homeostasis by improving insulin sensitivity and increasing glucose-stimulated insulin secretion (GSIS) from the β-cells. Here, we report that intraperitoneal treatment with one of HN analogs, HNG, decreases body weight gain, visceral fat, and hepatic triglyceride (TG) accumulation in high-fat diet-fed mice. The decrease in hepatic TG accumulation is due to increased activity of hepatic microsomal triglyceride transfer protein (MTTP) and increased hepatic TG secretion. Both intravenous (iv) and intracerebroventricular (icv) infusion of HNG acutely increase TG secretion from the liver. Vagotomy blocks the effect on both iv and icv HNG on TG secretion, suggesting that the effects of HNG on hepatic TG flux are centrally mediated. Our data suggest that HN is a new player in central regulation of peripheral lipid metabolism. Topics: Adiposity; Animals; Anti-Obesity Agents; Carrier Proteins; Cells, Cultured; Central Nervous System Agents; Diet, High-Fat; Hepatocytes; Infusions, Intravenous; Infusions, Intraventricular; Intra-Abdominal Fat; Intracellular Signaling Peptides and Proteins; Liver; Male; Mice, Inbred C57BL; Models, Biological; Obesity; Peptides; Rats, Sprague-Dawley; Reproducibility of Results; Triglycerides; Vagotomy, Truncal | 2015 |